FDA 483 - UCLA Health Systems, Blood & Platelet Center - May 29, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of UCLA Health Systems, Blood & Platelet Center in Los Angeles, CA, revealed significant failures to follow written standard operating procedures. The firm did not adhere to its SOPs for managing adverse donor events, including timely follow-up with donors and completing required attempts for severe reactions. Additionally, compliance reviews for occurrence management reports were not completed within the specified timeframe, indicating systemic issues with recordkeeping and quality management.
ID · 638f3c29-29a9-4af6-9e4b-1e0f840a6567